Close Menu

NEW YORK (GenomeWeb) – Analyzing hereditary cancer gene panel test results for the first 10,000 patients referred to its laboratory, researchers at GeneDx and their collaborators have found that almost one in 10 patients harbored either a pathogenic or a likely pathogenic variant.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.